Company profile for Marius Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Marius is a specialty pharmaceutical company focusing on treating conditions that are primarily associated with hypogonadism, commonly referred to as testosterone deficiency. The company’s mission is to improve the functional lives of patients and reduce the risks of the downstream effects of endocrine imbalance by ensuring appropriate level of testosterone. Marius pharmaceuticals is a cutting-edge biopharma company focusing...
Marius is a specialty pharmaceutical company focusing on treating conditions that are primarily associated with hypogonadism, commonly referred to as testosterone deficiency. The company’s mission is to improve the functional lives of patients and reduce the risks of the downstream effects of endocrine imbalance by ensuring appropriate level of testosterone. Marius pharmaceuticals is a cutting-edge biopharma company focusing on treating widespread conditions that have been triggered primarily through Androgen deficiency. Our pipeline consists of assets focused on inflammation and cardiovascular conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
8601 Six Forks Road Suite 630 Raleigh, NC 27615
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/12/3186364/0/en/Marius-Pharmaceuticals-Expands-Global-Footprint-with-Health-Canada-Approval-of-KYZATREX-testosterone-undecanoate-CIII-Capsules.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180418/0/en/Marius-Pharmaceuticals-Leads-Effort-to-Redefine-Women-s-Health-Through-Testosterone-Research.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/09/10/3147991/0/en/Marius-Pharmaceuticals-and-Hims-Hers-Collaborate-to-Expand-Access-to-KYZATREX-testosterone-undecanoate-CIII-Capsules-the-First-FDA-Approved-Oral-Testosterone-Therapy-Offered-on-the.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/05/28/3089515/0/en/Marius-Pharmaceuticals-Receives-Sixth-U-S-Patent-Allowance-for-KYZATREX-testosterone-undecanoate-CIII-Capsules-Extending-Coverage-to-2040.html

GLOBENEWSWIRE
28 May 2025

https://www.globenewswire.com/news-release/2025/04/22/3065576/0/en/Marius-Pharmaceuticals-Welcomes-John-Shrek-Mcphee-as-Kyzatrex-testosterone-undecanoate-CIII-Capsules-Patient-Ambassador.html

GLOBENEWSWIRE
22 Apr 2025

https://www.globenewswire.com/news-release/2025/03/25/3048815/0/en/Marius-Pharmaceuticals-Strengthens-IP-Portfolio-with-New-KYZATREX-testosterone-undecanoate-CIII-Capsules-Formulation-Patent.html

GLOBENEWSWIRE
25 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty